ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,416.45
-0.09%
Dow Jones
39,872.99
0.17%
Gold vs US Dollar
2,421.08
-0.22%
Brent Oil
82.415
-1.33%
Bitcoin
69,590.83
-2.60%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Canada
  5. CSE
  6. Neonmind Biosciences inc (NEON)

  7. Neonmind Biosciences inc (NEON) News

Neonmind Biosciences (NEON)

Neonmind Biosciences inc
Date:
Sort by:
 Showing the most relevant articles for your search:CSE:NEON
DateTimeSourceHeadlineSymbolCompany
28/09/202111:45InvestorsHub NewsWireNeonMind Advances Strategy for Specialty Clinic LaunchCSE:NEONNeonmind Biosciences inc
22/09/202111:30InvestorsHub NewsWireNeonMind Strengthens its Specialty Clinics Advisory Board with Appointment of Mood Disorders and Ketamine Expert Dr. Gustavo Vazquez, MD, PhDCSE:NEONNeonmind Biosciences inc
16/09/202116:39InvestorsHub NewsWireNeonMind Appoints Ketamine and Neurostimulation Expert Dr. Roumen Milev, MD, PhD to Specialty Clinic Advisory BoardCSE:NEONNeonmind Biosciences inc
08/09/202111:31InvestorsHub NewsWireNeonMind to Present at H.C. Wainwright 23rd Annual Global Investment ConferenceCSE:NEONNeonmind Biosciences inc
28/07/202112:03InvestorsHub NewsWireDr. Sagar Parikh, MD Appointed to NeonMind Specialty Clinics Advisory BoardCSE:NEONNeonmind Biosciences inc
29/06/202113:50InvestorsHub NewsWireNeonMind Announces Launch of Functional Mushroom Coffees as Dietary Supplements in the USCSE:NEONNeonmind Biosciences inc
10/06/202112:57InvestorsHub NewsWireNeonMind Announces Vitasave Will Carry NeonMind Functional Mushroom ProductsCSE:NEONNeonmind Biosciences inc
28/05/202113:24InvestorsHub NewsWireNeonMind to Commence Trading on the OTCQB Venture MarketCSE:NEONNeonmind Biosciences inc
06/04/202113:10InvestorsHub NewsWireNeonMind Developing Music Playlist for Psychedelic Therapy SessionsCSE:NEONNeonmind Biosciences inc
09/03/202113:00InvestorsHub NewsWireNeonMind Engages Pharma Executive Philippe Martin to Advance its Psilocybin Drug Candidates for ObesityCSE:NEONNeonmind Biosciences inc
24/02/202113:04InvestorsHub NewsWireNeonMind Purchases GMP Grade Synthetic Psilocybin from Psygen Labs for Phase 2 Human Clinical TrialCSE:NEONNeonmind Biosciences inc
27/01/202113:04InvestorsHub NewsWireNeonMind Appoints Robert Tessarolo as President and Chief Executive OfficerCSE:NEONNeonmind Biosciences inc
 Showing the most relevant articles for your search:CSE:NEON

Your Recent History

NASDAQ
WHIT
Whittier
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved